NUCIEN PHARMA received the "Notice of Case Filing" from the China Securities Regulatory Commission

Zhitong
2025.09.30 11:24
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, NUCIEN PHARMA announced that the company recently received a "Notice of Case Filing" (No.: Zhen Jian Li An Zi 0132025024) issued by the China Securities Regulatory Commission (CSRC). Due to the company's suspected violations of annual report information disclosure, the CSRC has decided to file a case against the company in accordance with the Securities Law of the People's Republic of China, the Administrative Penalty Law of the People's Republic of China, and other laws and regulations

According to the Zhitong Finance APP, NUCIEN PHARMA (688189.SH) announced that the company recently received a "Notice of Case Filing" (No. Zhenjian Lian'an Zi 0132025024) issued by the China Securities Regulatory Commission (CSRC). Due to the company's suspected violations of annual report information disclosure, the CSRC decided to file a case against the company in accordance with the Securities Law of the People's Republic of China, the Administrative Penalty Law of the People's Republic of China, and other laws and regulations

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.